Moneycontrol
HomeNewsBusinessMarketsScrapping Obamacare would hit most pharma cos: Jeff Chowdhry

Scrapping Obamacare would hit most pharma cos: Jeff Chowdhry

Scrapping of Obamacare is sure to impact pharma companies both globally and Indian, said Jeff Chowdhry, Senior Portfolio Manager, LGM Investments.

November 10, 2016 / 10:03 IST
Story continues below Advertisement

Your browser doesn't support HTML5 video.

Analysing the impact of Donald Trump win on global and Indian markets Jeff Chowdhry, Senior Portfolio Manager, LGM Investments said he was not surprised or shocked having already been through the Brexit vote.Republican Donald Trump stunned the world on Tuesday by defeating heavily favored Hillary Clinton in the race for the White House.

He is also not worried about Trump's statements during his election campaign because people once in power do not necessarily do the things they say.

Story continues below Advertisement

However, scrapping of Obamacare is sure to impact pharma companies both globally and Indian, said Chowdhry.

Chowdhry said although the markets reacted negatively in the short-term, the medium-term outlook is positive because Trump has been talking about lowering corporation taxes, increasing investment and growth rate of US economy – all these will surely help world economy and emerging markets going forward.